15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Kodiak Sciences Inc, 6 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $58.00 to $66.00, so the covering firms are broadly aligned. The average target of $61.67 sits 76% above the current $35.07. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.99 next quarter toward $-3.75 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Strong Buy
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Kodiak Sciences Inc.
As of Sep, 5 of 5 firms rate KOD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KOD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.99
Range $-1.12 – $-0.89 · 5 analysts · -5% YoY
Next period, 5 analysts expect Kodiak Sciences Inc to earn $-0.99 a share (range $-1.12 – $-0.89), versus $-1.04 a year earlier. Full-year consensus is $-3.99, growing to $-3.75 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 5 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $34.4M next year.
Top analysts covering Kodiak Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KOD.
#1
Daniil Gataulin
Chardan Capital · Rank #22
Buy
$61.00+73.9% to target
Overall win rate
58%
+ Follow
#2
Anupam Rama
JP Morgan · Rank #75
Buy
$66.00+88.2% to target
Overall win rate
51%
+ Follow
#3
MC
Matthew Caufield
HC Wainwright & Co. · Rank #92
Buy
$58.00+65.4% to target
Overall win rate
54%
+ Follow
#4
UR
Umer Raffat
Evercore ISI
Buy
No targeton KOD
Coverage
—
+ Follow
#5
Michael Yee
UBS
Buy
$80.00+128.1% to target
Coverage
—
+ Follow
KOD stock forecast FAQ
What is KOD's average 12-month price target?+
The 3 analysts with a live target average $61.67 for Kodiak Sciences Inc over the next 12 months, ranging from a $66.00 high to a $58.00 low.
Is KOD stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 7 analyst ratings, 6 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KOD?+
The Street-high target is $66.00 (JP Morgan), and the Street-low is $58.00 (HC Wainwright & Co.). The average of all 3 active targets is $61.67.
How many Wall Street analysts cover KOD?+
7 analysts have an active rating on Kodiak Sciences Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering KOD?+
Among analysts who currently cover KOD, Daniil Gataulin of Chardan Capital has the strongest overall Quantellect track record (Rank #22). Their current call is Buy with a $61.00 target.
What is Kodiak Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.99 per share (range $-1.12 – $-0.89) across 5 analysts. Full-year EPS is projected at $-3.99, rising to $-3.75 the following year.
How much revenue is Kodiak Sciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $34.4M next year.
Have analysts been upgrading or downgrading KOD lately?+
As of Sep, 5 of 5 firms rate KOD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KOD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
